DRAGEN v4.4 - Advanced & comprehensive analysis

DRAGEN v4.4 is here with powerful new innovations that expand its impact across genomic and mulitomic analysis. This latest release brings easy-to-use oncology applications for Heme WGS and Solid WGS tumor-normal and a new analysis pineline for Minimal Residual Disease (MRD) enabling simplified and streamlined oncology workflows. DRAGEN v4.4 will also power samples to insights multiomic workflows with secondary analysis pipelines that are optimized for the latest Illumina assays. Continued advancements in germline and somatic pipelines enhance accuracy, including a significant increase in structural variant calling accuracy, and more. Hear about all the new features in the upcoming technical webinar on DRAGEN v4.4.

Learn about the latest advancements in DRAGEN including: 

• New pre-configured push-button analysis for clinical oncology research
• Enhanced pipelines for new Illumina multiomic assays
• Redefined structural variant (SV) calling accuracy with over a 30% accuracy improvement for SV
• Personalized pangenome reference for even better accuracy 
•  Support for new AWS F2 instances

Presenter

Shyamal Mehtalia
Director, Software Technical Product Management, Secondary Analysis
Illumina

Shyamal Mehtalia is the Director of Technical Product Management at Illumina where in close collaboration with development teams and customers, defines the features and roadmap for the Illumina flagship secondary analysis solution, DRAGEN. Shyamal joined Illumina in May 2018 as part of the Edico Genome acquisition, which invented the DRAGEN platform where he served as Director of Operations for three years. Prior to this he held a leadership role in the mobile wireless space to develop firmware. Shyamal holds a master’s degree in electrical engineering from Texas A&M University.

CAP# M-GL-03558